4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-24-035474
President and CEO acquired 18,028 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tesi Raymond Joseph · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-19 | Grant or award : show line 1 in the form | +18,028 | $8.32 | $149,993 | 1,538,726 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-19 | Grant or award : show line 2 in the form Common Stock Warrants (right to buy) | +18,028 | $0.13 | $2,254 | 18,028 | D |
Loading xslF345X05/ownership.xml…